Sat.Nov 07, 2020 - Fri.Nov 13, 2020

article thumbnail

UK study will evaluate aspirin as a potential COVID-19 treatment

Pharma Times

RECOVERY study will assess if drug can reduce risk of blood clots

147
147
article thumbnail

The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19

NY Times

The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI implementation for pharma and healthcare

pharmaphorum

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. With AI already the key engine for a growing list of consumer devices, the trend has created exciting opportunities for pharma and healthcare. “We have now entered a new phase of AI implementation where AI-based technology is expected to be foundational and not just a novel technology,” Abid Rahman, vice president, innovation,

article thumbnail

AI speeds adapting to post-COVID ‘new normal’: WhizAI

Outsourcing Pharma

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

139
139
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

New pricing models could improve access to innovative cancer drugs

Pharma Times

Conclusions made by a group of experts from academia and industry

146
146

More Trending

article thumbnail

Pharma brands must ‘up the ante’ in their digital presence

pharmaphorum

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. The pharma world is no exception, and this year both small and large players have made the transition – partly out of necessity – from a world that relied predominantly on the face-to-face side of doing business, into a new digital world.

article thumbnail

Novartis, Elsevier collaborate on risk-assessment tool

Outsourcing Pharma

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

article thumbnail

BREAKING NEWS: early data indicates Pfizer/BioNTech’s COVID-19 vaccine is 90% effective

Pharma Times

Phase III study of vaccine candidate involved 43,538 participants

Vaccines 137
article thumbnail

Pfizer’s Covid Vaccine: 11 Things You Need to Know

NY Times

What’s the big deal? Was it part of Operation Warp Speed? When can you get one?

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Russia claims 92% efficacy for Sputnik COVID-19 shot

pharmaphorum

In the second positive piece of COVID-19 vaccine news in a week, Russia’s Sputnik V candidate has been shown to be 92% effective at the interim point of a 40,000-patient study. The preliminary assessment is based on 20 coronavirus cases split between the vaccinated and placebo arms of the study at 21 days, according to a press statement issued this morning by the Gamaleya Institute which developed the shot and the Russian Direct Investment Fund (RDIF).

Vaccines 116
article thumbnail

Joe Biden appoints COVID-19 Advisory Board

Outsourcing Pharma

President-elect Joe Biden has launched a Transition COVID-19 Advisory Board to support the USâ COVID-19 response.

97
article thumbnail

Russian says its ‘Sputnik V’ COVID-19 vaccine is 92% effective

Pharma Times

Interim data analysis comes from phase III clinical trials in the Russian Federation

Vaccines 130
article thumbnail

Shot to Prevent H.I.V. Works Better Than Daily Pill in Women

NY Times

Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills.

89
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Controversial US data firm Palantir could manage UK’s ailing Test and Trace scheme

pharmaphorum

US data analysis company Palantir Technologies could be drafted in to manage the UK government’s troubled COVID-19 Test and Trace programme, according to press reports. Palantir has been linked with the project for several weeks and the Financial Times is the latest to suggest that the company could get involved with the troubled project. Palantir was founded in 2003 by a team including paypal co-founder Peter Thiel and the company’s billionaire CEO Alex Karp.

article thumbnail

Eversana, Evoke Pharma partner on nasal drug for patients with diabetic gastroparesis

Outsourcing Pharma

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

article thumbnail

Waylivra, Tecentriq and more accepted by SMC

Pharma Times

Akcea’s Waylivra approved via ultra-orphan pathway

130
130
article thumbnail

When Medicare Choices Get ‘Pretty Crazy,’ Many Seniors Avert Their Eyes

NY Times

A new study shows that more than half of enrollees don’t review or compare their coverage options annually.

77
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Health Innovators: David Van Sickle on digital innovation in respiratory medicine

pharmaphorum

In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respiratory medicine. The post Health Innovators: David Van Sickle on digital innovation in respiratory medicine appeared first on.

111
111
article thumbnail

NIH: hydroxychloroquine no use to hospitalized COVID-19 patients

Outsourcing Pharma

Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.

article thumbnail

Mallinckrodt launches retrospective study for inhaled therapy in COVID-19

Pharma Times

Study will collect real-world data on use of INOmax in COVID-19 patients

130
130
article thumbnail

Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

NY Times

The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.

73
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Switzerland’s Synendos raises CHF 20m for CNS drug development

pharmaphorum

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be used to develop its endocannabinoid drugs for central nervous system disorders. The Basel-based biotech – which was incubated in Switzerland’s BaseLaunch accelerator – is concentrating on developing a new class of small-molecule drugs for anxiety, mood and stress-related disorders.

article thumbnail

Which pharmaceutical companies have the most elixir dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most elixir dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most elixir dosed drugs…. The post Which pharmaceutical companies have the most elixir dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

UCB acquires gene therapy specialist Handl Therapeutics

Pharma Times

Company also announces new collaboration with Lacerta Therapeutics

127
127
article thumbnail

Esposos, científicos, inmigrantes: las mentes detrás de la vacuna contra el coronavirus

NY Times

La compañía alemana BioNTech, fundada por dos científicos, se ha asociado con Pfizer en una vacuna cuya eficacia se ha comprobado en más de un 90 por ciento.

70
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.